⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DYN News
Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
DYN
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
globenewswire.com
DYN
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
globenewswire.com
DYN
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy
globenewswire.com
DYN